
CCEP · Nasdaq
Consensus is Buy across 10 analysts, with a mean price target of $112. The supplied data gives no low or high target, so the target cluster and breadth of the spread cannot be established. No named analyst or firm is identified, preventing attribution of the most bullish or least bullish view. The evidence also reports no rating or price-target changes during the week, so the direction of revisions is unavailable. The substantive disagreement visible in the record is between improving fundamentals—higher first-half revenue, operating profit and EPS, plus volume and share gains—and the 4.77% share-price decline after results and confirmation of fiscal 2026 guidance.
